For the Inventor, By the Inventor

Enter assignee name

Alfasigma S.p.a.

USPTO Granted Patents = 22

CIPO Patents = 11

EPO Patents = 19

Trademarks = 37

Forward Citations = 6

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Giuseppe Claudio Viscomi (9 out of 40 patents)

Andrea Biffi (5 out of 13 patents)

Walter Fiore (5 out of 8 patents)

4. Paola Maffei (4 out of 10 patents)

5. Ruggero Rossi (3 out of 6 patents)

6. Annalisa Sforzini (2 out of 3 patents)

7. Maria Grimaldi (2 out of 2 patents)

8. Carla De Faveri (1 out of 21 patents)

9. Marco Mascagni (1 out of 1 patent)

10. Ahmad Y Sheikh (1 out of 26 patents)

11. Christel Jeanne Marie Menet (1 out of 29 patents)

12. Koen Kurt Smits (1 out of 11 patents)

13. Nicolas Luc Sabourault (1 out of 6 patents)

14. Pierluigi Mangino (1 out of 1 patent)

15. Marina Elli (1 out of 1 patent)

22 patents: Sort by Forward Citations

1. 12502394 - Pharmaceutical compositions comprising a JAK inhibitor (2025-12-23),

2. 12447183 - Bacterial strains, their compositions and their use for the treatment of gastrointestinal disorders (2025-10-21),

3. 12329758 - Methods for the treatment of psoriatic arthritis (2025-06-17),

4. 12234235 - Salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2025-02-25),

5. 12201729 - Process for mesalazine solid formulations (2025-01-21),

6. 12042498 - Compound useful for the treatment of degenerative and inflammatory diseases (2024-07-23),

7. 11896631 - Probiotics for use in the treatment of diverticulosis and diverticular disease (2024-02-13),

8. 11839634 - Use of a composition comprising microorganisms to increase the intestinal production of butyric acid, folic acid or niacin and/or decrease the intestinal production of succinic acid (2023-12-12),

9. 11752179 - Medical use of probiotics (2023-09-12),

10. 11751597 - Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems (2023-09-12),

11. 11642339 - Methods of treating symptoms of gastroparesis using velusetrag (2023-05-09),

12. 11433043 - Compounds useful for increasing neurogenesis in neural tissue (2022-09-06),

13. 11241452 - Oral compositions for the treatment of gastroesophageal reflux (2022-02-08),

14. 10793925 - for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereof (2020-10-06),

15. 10703763 - Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations (2020-07-07),

Alfasigma is an Italian multinational pharmaceutical company that develops, manufactures, and distributes a wide range of pharmaceutical products worldwide. With a focus on research, innovation, and sustainability, Alfasigma aims to provide high-quality solutions for healthcare professionals and patients. The company operates in various therapeutic areas, including gastroenterology, respiratory, psychiatry, and pain management, delivering innovative treatments to improve patient outcomes and quality of life. For more information about Alfasigma and its products, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#9 in Bologna

#384 in Italy

#27,908 in the World

Alfasigma S.p.a.

Forward Citations = 6

48 inventors:

Giuseppe Claudio Viscomi (9 out of 40 patents)

Andrea Biffi (5 out of 13 patents)

Walter Fiore (5 out of 8 patents)

4. Paola Maffei (4 out of 10 patents)

5. Ruggero Rossi (3 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…